Stockscreener 앱 받기
0.597
0.55%
-0.0033
시간 외 거래:
.60
0.003
+0.50%
전일 마감가:
$0.6003
열려 있는:
$0.5992
하루 거래량:
667.39K
Relative Volume:
0.71
시가총액:
$58.97M
수익:
$301.71M
순이익/손실:
$-201.99M
주가수익비율:
-0.3118
EPS:
-1.9144
순현금흐름:
$13.79M
1주 성능:
+7.45%
1개월 성능:
+7.43%
6개월 성능:
-33.23%
1년 성능:
-60.20%
1일 변동 폭
$0.5635
$0.6274
1주일 범위
$0.5307
$0.6274
52주 변동 폭
$0.4511
$1.7799
Docgo Inc Stock (DCGO) Company Profile
명칭
Docgo Inc
전화
(844) 443-6246
주소
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
0.597 | 58.97M | 301.71M | -201.99M | 13.79M | -1.9144 |
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-08-18 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-01-19 | 개시 | Stifel | Buy |
| 2021-12-21 | 개시 | Canaccord Genuity | Buy |
| 2021-12-07 | 개시 | Needham | Buy |
모두보기
Docgo Inc 주식(DCGO)의 최신 뉴스
DCGO Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherEPS Guidance Update - dars.gov.et
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
DocGo Extends $26 Million Share Repurchase Program - TipRanks
DocGo extends $26M share repurchase program expiration to Dec. 31, 2026 - TradingView
DocGo (NASDAQ: DCGO) extends $26M share repurchase program to year-end 2026 - Stock Titan
DCGO Q1 2026 Earnings: EPS Misses Estimates Despite Stock SurgeGuidance Upgrade Report - dars.gov.et
DCGO Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin, Yet Stock Rises 6.5%Annual Earnings Summary - dars.gov.et
Price to sales forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Enterprise value to EBITDA forward of DocGo Inc. – NASDAQ:DCGO - TradingView
Price to book forward of DocGo Inc. – NASDAQ:DCGO - TradingView
DocGo Inc. Actuals & Estimates (NASDAQ:DCGO) - TradingView
DCGO Forecast — Price Target — Prediction for 2027 - TradingView
DocGo Inc.'s Equity Buyback Plan Extended till December 31, 2026. - marketscreener.com
DocGo Inc (DCGO) Institutional Confidence - TradingKey
DocGo Inc (DCGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DCGO Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 7.5%Financial Health Score - dars.gov.et
DocGo shareholders approve reverse stock split and board nominees at annual meeting - Investing.com UK
DocGo Shareholders Approve Reverse Split, Elect Directors - TipRanks
DocGo (NASDAQ: DCGO) holders OK reverse split and reject officer exculpation - Stock Titan
DocGo Inc (DCGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
DocGo Inc (DCGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DocGo Inc (DCGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DocGo Inc (DCGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DocGo Inc (DCGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DocGo Inc (DCGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DocGo Inc (DCGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DCGO: Board transitions, proposal approvals, and record growth highlight a pivotal year - TradingView
DocGo (DCGO) Holds Near Support at $0.55 as Trading Volume Remains SubduedFibonacci Retracement - dars.gov.et
DocGo Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesSegment Revenue Breakdown - newsline.com
DocGo (DCGO) Goldman Sachs 47th Annual Global Healthcare Conference 2026 Summary - Quartr
DCGO: Transitioning to proactive, tech-enabled care, the company targets growth and profitability - TradingView
DocGo launches mobile phlebotomy services in southern Florida By Investing.com - Investing.com India
DocGo launches mobile phlebotomy services in southern Florida - Investing.com
DocGo Launches Mobile Phlebotomy Services in South Florida - Business Wire
At-home blood draws come to South Florida as DocGo expands - Stock Titan
DocGo Q1 2026 Earnings: EPS Misses Estimates by 36.55% as Profitability Challenges PersistBuyback Announcement Report - newsline.com
DocGo Inc. (DCGO) Edges Upward Amidst Narrow Trading RangeNegative Gamma - newsline.com
DocGo Q1 2026 Earnings: EPS Misses Estimates as Losses WidenInvestor Earnings Call - thelegaladvocate.com
DocGo (DCGO) price target decreased by 10.71% to 1.91 - MSN
DCGO|DocGo Inc|Price:0.658|Chg%:0.00 - TradingKey
DocGo targets profitability as it pivots to mobile health, medical transport - MSN
DCGODocGo Inc Stock Price and Quote - Finviz
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
DocGo Inc. (DCGO) Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesSocial Flow Trades - Newser
DocGo Inc. (DCGO) Navigates Resistance at $0.63 as Shares Edge LowerWeak Sell Signals - thelegaladvocate.com
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth - MSN
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets - Yahoo Finance
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport - sharewise.com
DocGo Inc.Common Stock (NQ: DCGO - The Chronicle-Journal
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results - Sahm
Docgo Inc (DCGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.88%
0.24%
자본화:
|
볼륨(24시간):